UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
_________________
FORM 10-QSB/A
_________________
(Mark One)
|X| Quarterly Report Under Section 13 Or 15(d)
Of The Securities Exchange Act Of 1934
For The Quarterly Period Ended September 30, 2003
|_| Transition Report Under Section 13 Or 15(d)
Of The Securities Exchange Act Of 1934
For The Transition Period From ________ To _______.
Commission File No. _______
RECOM MANAGED SYSTEMS, INC.
(Exact name of small business issuer as specified in its charter)
Delaware | 87-0441351 |
(State or other jurisdiction of | (I.R.S. Employer |
incorporation or organization) | Identification No.) |
4705 Laurel Canyon Boulevard, Suite 203
Studio City, California 91607 (818) 432-4560
(Address Of Principal Executive Offices) (Issuer's Telephone Number)
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: YES |X| NO |_|
State the number of shares outstanding of each of the issuers classes of common equity, as of the latest practicable date: 32,169,125 shares of common stock, par value $0.001 per share, as of October 31, 2003.
|
September 30, 2003 |
|||
|
||||
ASSETS
|
|
|||
|
|
|||
CURRENT ASSETS - cash
|
$ |
2,979 |
||
|
|
|||
Equipment, net of accumulated depreciation
|
165,084
|
|||
Intangible assets - patents
|
167,729
|
|||
|
||||
TOTAL ASSETS
|
$ |
335,792
|
||
|
||||
|
|
|||
|
|
|||
LIABILITIES & STOCKHOLDERS' EQUITY
|
|
|||
|
|
|||
CURRENT LIABILITIES - accrued expenses
|
$ |
179,360
|
||
STOCKHOLDERS' EQUITY
|
|
|||
Common stock, $.001 par value; 100,000,000
shares authorized; 32,153,740 shares issued and outstanding |
32,153
|
|||
Additional paid-in capital
|
4,297,484
|
|||
Deferred compensation
|
(445,492
|
) |
||
Deficit accumulated during development
stage |
(3,727,713
|
) |
||
|
||||
TOTAL STOCKHOLDERS' EQUITY
|
156,432
|
|||
|
||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ |
335,792
|
||
|
The accompanying notes are an integral part of these financial statements.
2
|
For the Nine
Months Ended September 30,
(As Restated)
|
From Inception of Development
Stage (November 7, 2000) to September 30, 2003 |
|||||||||
|
|
||||||||||
|
2003
|
2002
|
(As Restated) |
||||||||
|
|
||||||||||
Revenue |
$ |
|
$ |
|
$ |
|
|||||
Research and development |
166,910 |
|
234,410 |
||||||||
General and administrative expenses
|
3,262,175 |
49,341 |
3,493,303 |
||||||||
|
|
|
|||||||||
Loss before income tax provision
|
(3,429,086 |
) |
(49,341 |
) |
(3,727,713 |
) |
|||||
Provision for income taxes |
|
|
|
||||||||
|
|
|
|||||||||
Net loss |
$ |
(3,429,086 |
) |
$ |
(49,341 |
) |
$ |
(3,727,713 |
) |
||
|
|
|
|||||||||
Basic and diluted loss per share
|
$ |
(0.11 |
) |
$ |
(0.01 |
) |
$ |
(0.27 |
) |
||
|
|
|
|||||||||
Weighted average shares outstanding
- basic and diluted |
31,525,497 |
5,232,641 |
13,816,910 |
||||||||
|
|
|
The accompanying notes are an integral part of these financial statements.
3
RECOM MANAGED SYSTEMS,
INC.
|
|
|
|
|
|
|
|
|
Deficit Accumulated During Development Stage |
|
||||||
|
|
|
|
|
Additional
Paid-in
Capital
|
|
Deferred
Compensation
|
|
|
|||||||
|
Common Stock
|
|
|
|
|
|||||||||||
|
||||||||||||||||
|
Shares
|
Amount
|
Total | |||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance November 7, 2000 (as restated
for 3:1 stock split) |
4,139,784 |
|
$ |
4,139 |
$ |
(4,139) |
$ |
|
$ |
|
$ |
|
||||
Contributed capital |
|
|
|
35,000 |
|
|
35,000 |
|||||||||
Net loss |
|
|
|
|
|
(36,673) |
(36,673) |
|||||||||
|
|
|
|
|
|
|||||||||||
Balance December 31, 2000 |
4,139,784 |
|
4,139 |
30,861 |
|
(36,673) |
(1,673) |
|||||||||
Contributed capital |
|
|
|
45,000 |
|
|
45,000 |
|||||||||
Shares issued for services July 2001
- $0.033 |
150,000 |
|
150 |
4,850 |
|
|
5,000 |
|||||||||
Net loss |
|
|
|
|
|
(50,000) |
(50,000) |
|||||||||
|
|
|
|
|
|
|||||||||||
Balance December 31, 2001 |
4,289,784 |
|
4,289 |
80,711 |
|
(86,673) |
(1,673) |
|||||||||
Capital contributed |
|
|
|
56,400 |
|
|
56,400 |
|||||||||
Warrants issued for Cash |
|
|
|
125,000 |
|
|
125,000 |
|||||||||
Issuance of common stock: |
|
|
|
|
|
|
|
|||||||||
Technology
Sept. 2002 - $0.006 |
23,400,000 |
|
23,400 |
4,623 |
|
|
78,023 |
|||||||||
Services
rendered - Oct. 2002 - $0.021 |
2,925,000 |
|
2,925 |
17,958 |
(19,678) |
|
1,205 |
|||||||||
Cash
Oct 2002 - $0.03 |
564,810 |
|
565 |
17,221 |
|
|
17,786 |
|||||||||
Cash
Nov 2002 - $2.66 |
71,250 |
|
71 |
189,929 |
|
|
190,000 |
|||||||||
Contributed services - officer
|
|
|
|
20,000 |
|
|
20.000 |
|||||||||
Warrants issued for services |
|
|
|
5,324 |
|
|
5,324 |
|||||||||
Net loss |
|
|
|
|
|
(211,954) |
(211,954) |
|||||||||
|
|
|
|
|
|
|||||||||||
Balance December 31, 2002 |
31,250,844 |
|
$ |
31,250 |
$ |
567,166 |
$ |
(19,678) |
$ |
(298,627) |
$ |
280,111 |
4
|
|
|
|
|
|
|
|
|
Deficit Accumulated During Development Stage |
|
||||||
|
|
|
|
|
Additional
Paid-in
Capital
|
|
Deferred
Compensation
|
|
|
|||||||
|
Common Stock
|
|
|
|
|
|||||||||||
|
||||||||||||||||
|
Shares
|
Amount
|
Total | |||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Issuance of common stock for cash and
contributed property - April 2003- $2.22 |
112,812 |
|
$ |
113 |
|
$ |
249,887 |
|
$ | |
|
$ | |
|
$ |
250,000 |
Issuance of common stock for cash:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
May 2003
- $3 |
82,667 |
|
83 |
|
247,917 |
|
|
|
|
|
248,000 |
|||||
May 2003
- $3.33 |
75,075 |
|
75 |
|
249,925 |
|
|
|
|
|
250,000 |
|||||
Issuance of common stock for services:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
April 2003
- $2.80 |
147,192 |
|
147 |
|
411,653 |
|
|
|
|
|
411,800 |
|||||
April 2003
- $3.14 |
11,045 |
|
11 |
|
34,780 |
|
|
|
|
|
34,791 |
|||||
Issuance of common stock for services:
|
|
|
|
|
|
|
|
|
|
|
|
|||||
April 2003
- $3.705 |
111,625 |
|
112 |
|
413,459 |
|
|
|
|
|
413,571 |
|||||
August
2003 - $3.705 |
33,188 |
|
33 |
|
122,929 |
|
|
|
|
|
122,962 |
|||||
September
2003 - $3.705 |
24,292 |
|
24 |
|
89,982 |
|
|
|
|
|
90,006 |
|||||
Cashless exercise of warrants
|
305,000 |
|
305 |
|
(305) |
|
|
|
|
|
|
|||||
Contributed services - officer
|
|
|
|
|
56,203 |
|
|
|
|
|
56,203 |
|||||
Employee stock options issued at below
market |
|
|
|
|
38,400 |
|
|
|
|
|
38,400 |
|||||
Amortization of deferred compensation
|
|
|
|
|
|
|
6,356 |
|
|
|
6,356 |
|||||
Warrants issued for: |
|
|
|
|
|
|
|
|
|
|
|
|||||
Services
|
|
|
|
|
1,741,399 |
|
(432,170) |
|
|
|
1,309,229 |
|||||
Financing
cost |
|
|
|
|
74,088 |
|
|
|
|
|
74,088 |
|||||
Net loss |
|
|
|
|
|
|
|
|
(3,429,086) |
|
(3,429,086) |
|||||
|
|
|
|
|
|
|||||||||||
Balance September 30, 2003 (unaudited)
|
32,153,740 |
|
$ |
$32,153 |
|
$ |
4,297,484 |
|
$ |
(445,492) |
|
$ |
(3,727,713) |
|
$ |
156,432 |
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements.
5
|
For Nine Months Ended September 30,
|
From Inception of Development Stage (November
7, 2000) to September 30, 2003 |
||||||||
|
|
|||||||||
|
2003
|
2002
|
||||||||
|
|
|||||||||
Cash flow from operating activities
|
|
|
|
|||||||
Net loss |
$ |
(3,429,086 |
) |
$ |
(49,341 |
) |
$ |
(3,727,713 |
) |
|
Adjustments to reconcile net loss to
net cash used in operating activities |
|
|
|
|||||||
Depreciation |
21,522 |
|
22,215 |
|||||||
Amortization of deferred compensation
|
6,356 |
|
6,356 |
|||||||
Services as contributed capital
|
56,203 |
|
76,203 |
|||||||
Common stock issued for services
|
1,141,071 |
5,000 |
1,147,276 |
|||||||
Warrants issued for services
|
1,286,985 |
|
1,292,309 |
|||||||
Change in assets & liabilities:
|
|
|
|
|||||||
Prepaid expenses |
37,815 |
|
|
|||||||
Accrued expenses |
139,596 |
1,500 |
153,360 |
|||||||
|
|
|
||||||||
|
|
|
|
|||||||
Cash used in operating activities
|
(739,538 |
) |
(42,841 |
) |
(1,029,994 |
) |
||||
|
|
|
||||||||
|
|
|
|
|||||||
Cash flows from investing activities
- |
|
|
|
|||||||
Purchase of equipment |
(41,466 |
) |
|
(70,507 |
) |
|||||
Capitalized technology cost
|
(62,706 |
) |
|
(62,706 |
) |
|||||
|
|
|
|
|||||||
Cash used in investing activities
|
(104,172 |
) |
|
(133,213 |
) |
|||||
Cash flow from financing activities:
|
|
|
|
|||||||
Capital contributions |
|
35,000 |
135,400 |
|||||||
Sale of common stock for cash
|
598,000 |
125,000 |
905,786 |
|||||||
Sale of warrants for cash |
|
|
125,000 |
|||||||
|
|
|
||||||||
Net cash provided by financing activities
|
598,000 |
160,000 |
1,166,186 |
|||||||
|
|
|
|
|||||||
Net increase (decrease) in cash
|
(145,710 |
) |
117,159 |
2,979 |
||||||
|
|
|
|
|||||||
Cash at beginning of period
|
148,689 |
8,262 |
|
|||||||
|
|
|
||||||||
|
|
|
|
|||||||
Cash at end of period |
$ |
2,979 |
$ |
125,421 |
$ |
2,979 |
||||
|
|
|
The accompanying notes are an integral part of these financial statements.
6
For the nine months ended September 30, 2003, and from inception of development stage (November 7, 2000), the Company paid no interest or income taxes.
For the nine months ended September 30, 2003, the Company issued warrants to consultants to purchase the Companys common stock under consulting agreements. The value of the warrants based upon the fair value of the stock at the measurement dates using the Black-Scholes option model is $ 1,815,407. The Company recorded compensation expense of $1,383,317 for those agreements.
The Company recorded $56,203 of compensation expense for the CEO of the Company. This compensation was recorded as additional paid in capital for the nine months ended September 30, 2003.
The accompanying notes are an integral part of these financial statements.
7
As reflected in the accompanying financial statements, the Company has losses from inception, negative cash flows from operations, limited working capital and no established source of revenue. These matters raise substantial doubt about the Company's ability to continue as a going concern.
The Company has raised approximately $$4,806,000 through the sale of series 'A' convertible stock that will be used to fund any capital shortfalls. See Note 5 for further details.
RECOM MANAGED SYSTEMS, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
For The Nine Months Ended September 30, 2003 And 2002 From Inception
Of Development Stage (November 7, 2000) To September 30, 2003
2. STOCK OPTIONS
|
Nine Month Period
Ended
September 30, 2003 |
Nine Month Period
Ended
September 30, 2002 |
|||||
|
|
||||||
Net loss, attributable to common shareholders
as reported |
$ |
(3,429,086 |
) |
$ |
(49,341 |
) |
|
Current period expense |
242,550 |
|
|||||
Stock compensation calculated under APB
25 |
(459,241 |
) |
|
||||
|
|
||||||
Pro forma net loss |
$ |
(3,645,777 |
) |
$ |
( 49,341 |
) |
|
|
|
||||||
Basic and diluted historical loss per
share available to common shareholders |
$ |
(0.12 |
) |
$ |
(0.01 |
) |
|
Pro forma basic and diluted loss per
share available to common shareholders |
$ |
(0.12 |
) |
$ |
(0.01 |
) |
Dr. Lowell T. Harmison, one of the Company's Directors, provides consulting services to the Company under a three year agreement dated February 14, 2003. Under this agreement, Dr. Harmison provides advice to the Company in the areas of technological support and strategy, product development, medical and scientific advisory board development, and FDA regulation. The compensatory terms of the agreement are as follows:
9
RECOM MANAGED SYSTEMS, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
For The Nine Months Ended September 30, 2003 And 2002 From Inception
Of Development Stage (November 7, 2000) To September 30, 2003
The Company is obligated to pay Dr. Harmison $36,000 per year over the term of the agreement, payable quarter. Dr. Harmison was entitled to receive upon execution of the agreement an initial grant of options entitling him to purchase 108,000 common shares (36,000 shares pre split) at $0.97 per share, exercisable over five years. The fair value of warrants was $153,352 estimated using the Black-Scholes option-pricing model computed as of the measurement date, which is the date that the service were performed, with thee following assumptions: (i) dividend yield of 0%, (ii) expected volatility of 158.48%, (iii) weighed-average risk-free interest rate of approximately 3.13, and (iv) expected life of 1.5 years.
On the date of Dr Harmison's execution of the agreement, as well as the commencement of the first and second years of service under the agreement, the Company is obligated to grant Dr. Harmison options entitling him to purchase 108,000 (36,000 pre-split) common shares at $0.97 per share, exercisable over five years; except that these options will vest quarterly based upon his provision of services over the first year of the agreement.
Dr. Harmison is entitled to receive common shares grants in tranches of 20,000 common shares per milestone for assisting the Company in attaining various milestones determined by the Company's Board of Directors, including the preparation and filing with the FDA of a 510(k) application for the Company's product, approval of that application by the FDA, and market launch of that product.
A grant of 20,000 common shares in the event of a "change in control" as that term is defined in the agreement.
In March 2003, for services rendered, the Company recognized a total of $14,000 in expense in connection with the issuance of warrants. The fair value of warrants was recorded using the Black-Scholes option-pricing model computed as of the date of grant using the following assumptions: (i) dividend yield of 0%, (ii) expected volatility of 158.48%, (iii) weighed-average risk-free interest rate of approximately 3.13, and (iv) expected life of 1.5 years.
In March 2003, the Company entered into an agreement with its then CFO to issue him warrants to purchase 900,000 (300,000 pre-split) shares of the Companys common stock at $0.95 per share. The warrants were issued as compensation for services. The warrants vest quarterly over a 3-year period. The warrants have been valued using the Black-Scholes value option method; with a measurement date as the date the services are rendered. The fair value of warrants was estimated at $204,170 using the Black-Scholes option-pricing model computed as of the date of grant using the following assumptions: (i) dividend yield of 0%, (ii) expected volatility of 158.48%, (iii) weighed-average risk-free interest rate of approximately 3.13, and (iv) expected life of 1.5 years.
10 RECOM MANAGED SYSTEMS, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
For The Nine Months Ended September 30, 2003 And 2002 From Inception
Of Development Stage (November 7, 2000) To September 30, 2003
In March 2003, the Companys Board of Directors approved the issuance of five-year warrants to purchase 900,000 shares (300,000 pre-split) of the Companys common stock at $.50 per share to a business advisory consulting firm retained to perform various services including: the introduction of the Company to investment banking firms; assistance in the structuring of the Companys private offerings; assistance in capital market transactions, mergers and acquisitions; advisory services; and assistance in developing strategic relationships. The fair value of warrants was estimated at $657,779 using the Black-Scholes option-pricing model computed as of the date of grant using the following assumptions: (i) dividend yield of 0%, (ii) expected volatility of 158.48%, (iii) weighed-average risk-free interest rate of approximately 1.65, and (iv) expected life of 1.5 years.
On April 1, 2003, the Company completed the private placement of 112,792 (37,604 pre-split) shares of its common stock for a total consideration of $250,000. The consideration included $100,000 in cash and the cancellation of $150,000 of debt previously advanced for $33,208 in expenses and $116,792 of leasehold improvements.
On April 2, 2003, the Board of Directors declared a three-for-one stock split effective as of the close of business on Friday, April 11, 2003. All share amounts and earnings per share have been presented on a post split basis.
On April 15, 2003, the Company committed to issue to Brookstreet Securities Corporation warrants to purchase 200,000 shares of the Companys common stock pursuant to an investment banking agreement. The warrants are issuable in four tranches of 50,000 each, with the first tranche of 50,000 fully vested and exercisable at $1.25 per share. The second tranche will vest in 90 days after the date of the agreement and will have an exercise price of $2.25 per share. The third tranche will vest in 180 days and will have an exercise price of $3.25 per share. The fourth tranche will vest in 270 days and will have an exercise price of $4.25 per share. The fair value of warrants was estimated at $338,261 using the Black-Scholes option-pricing model computed as of the measurement date, which is the date the at the services were performed, using the following assumptions: (i) dividend yield of 0%, (ii) expected volatility of 114.24%, (iii) weighed-average risk-free interest rate of approximately 1.42, and (iv) expected life of 1.5 years.
On July 17, 2003 the Company retained Maxim Group, LLC ("Maxim") a New York based investment banking firm to act as its lead investment bank. Under that agreement Maxim provides, among other services, assistance with the Company's financing efforts as it attempts to secure additional capital for product development as well as to fund the process of gaining approval for the Company's cardiac monitoring device by the FDA. Maxim will also assist the Company with general business strategy and with seeking a listing on a national exchange. Maxim was paid $50,000 at the inception of the agreement and will be paid $7,500 per month through June 30, 2004. In addition, Maxim received a total of 100,000 warrants to purchase shares of restricted common stock at $4.92 per share. The fair value of warrants was estimated at $133,349 using the Black-Scholes option-pricing model computed as of the date of grant using the following assumptions: (i) dividend yield of 0%, (ii) expected volatility of 81.16%, (iii) weighed-average risk-free interest rate of approximately 1.68, and (iv) expected life of 1.5 years.
11
RECOM MANAGED SYSTEMS, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
For The Nine Months Ended September 30, 2003 And 2002 From Inception
Of Development Stage (November 7, 2000) To September 30, 2003
|
September 30, 2003
|
September 30, 2002
|
|||||||||||
|
|
||||||||||||
|
Number
|
Average Exercise Price
|
Number
|
Average Exercise Price
|
|||||||||
|
|
|
|
||||||||||
Outstanding at beginning of the period
|
|
|
|
|
|||||||||
Granted during the period |
2,560,000 |
$ |
0.98 |
|
|
||||||||
Exercised during the period
|
|
|
|
|
|||||||||
Terminated during the period
|
|
|
|
|
|||||||||
|
|
||||||||||||
Outstanding at end of the period
|
2,560,000 |
0.98 |
|
|
|||||||||
|
|
||||||||||||
Exercisable at end of the period
|
1,090,833 |
$ |
1.04 |
|
|
||||||||
|
|
RECOM MANAGED SYSTEMS, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
For The Nine Months Ended September 30, 2003 And 2002 From Inception
Of Development Stage (November 7, 2000) To September 30, 2003
Range of Exercise Prices |
|
Remaining Number Outstanding |
|
Weighted Average Contractual Life (Years) |
|
Weighted Average Fair Value |
|
Exercise Price |
0 to 1 |
|
2,490,000 |
|
4.3 |
|
$ 0.60 |
|
$ 0.90 |
1 to 2 |
|
|
|
|
|
|
|
|
2 to 3 |
|
10,000 |
|
4.5 |
|
1.90 |
|
2.85 |
3 to 4 |
|
10,000 |
|
4.8 |
|
2.50 |
|
3.19 |
4 to 5 |
|
50,000 |
|
4.7 |
|
2.80 |
|
4.20 |
|
September 30, 2003
|
September 30, 2002
|
|||||||||||
|
|
||||||||||||
|
Number
|
Average Exercise Price
|
Number
|
Average Exercise Price
|
|||||||||
|
|
|
|
||||||||||
Outstanding at beginning of the period
|
1,025,000 |
$ |
1.25 |
|
$ |
|
|||||||
Granted during the period |
1,426,501 |
1.12 |
575,000 |
0.71 |
|||||||||
Exercised during the period
|
|
|
|
|
|||||||||
Terminated during the period
|
|
|
|
|
|||||||||
Outstanding at end of the period
|
2,451,501 |
1.36 |
575,000 |
0.71 |
|||||||||
|
|
||||||||||||
Exercisable at end of the period
|
1,207,250 |
$ |
1.39 |
575,000 |
$ |
0.71 |
|||||||
|
|
Range of Exercise Prices |
|
Remaining Number Outstanding |
|
Weighted Average Contractual Life (Years) |
|
Weighted Average Fair Value |
|
Exercise Price |
0 to 1 |
|
971,000 |
|
3.6 |
|
$ 0.90 |
|
$ 0.53 |
1 to 2 |
|
131,000 |
|
2.9 |
|
2.24 |
|
1.14 |
2 to 3 |
|
158,000 |
|
5.6 |
|
2.10 |
|
2.35 |
3 to 4 |
|
48,501 |
|
4.9 |
|
1.60 |
|
3.24 |
4 to 5 |
|
118,000 |
|
4.9 |
|
1.47 |
|
4.98 |
13
RECOM MANAGED SYSTEMS, INC.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
For The Nine Months Ended September 30, 2003 And 2002 From Inception
Of Development Stage (November 7, 2000) To September 30, 2003
As part of the unit offering, the Company entered into registration rights agreements which require the Company to use its best efforts to file a registration statement with the Securities and Exchange Commission statement as soon as reasonably practicable after the first closing for the offering (October 1, 2003), but in no event less than 90 days following the first closing, to register the shares of common stock issuable upon conversion of the series 'A' convertible preferred stock and upon exercise of the class 'C' warrants. If the Company fails to do so, the exercise price for the class 'C' warrants will be reduced to $3 from $3.75.
14
Exhibits | |
31.1 | Certification of CEO Pursuant to Section 302 of the Sarbanes-Oxley Act * |
31.2 | Certification of CFO Pursuant to Section 302 of the Sarbanes-Oxley Act * |
32.1 | Certification of CEO Pursuant to Section 906 of the Sarbanes-Oxley Act * |
32.2 | Certification of CFO Pursuant to Section 906 of the Sarbanes-Oxley Act * |
SIGNATURES
In accordance with the requirements of the Exchange Act, the caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated at Studio City, California, this 24th day of May, 2004.
RECOM MANAGED SYSTEMS, INC. | ||
By: | /s/ Marvin H. Fink | |
Marvin H. Fink |
||
By: | /s/ Charles Dargan | |
Charles Dargan Interim Chief Financial Officer (principal accounting and financial officer) |
15